ITEM 7.01 REGULATION FD DISCLOSURE
On September 4, 2009, Mark A. Libratore, President and Chief Executive Officer
of Liberator Medical Holdings, Inc. (the "Company"), made a presentation at the
Company's annual meeting of shareholders in Stuart, Florida. The presentation is
filed as Exhibit 99.1 to this Report on Form 8-K.
The information under this caption, "Item 7.01 - Regulation FD Disclosure,"
including information in any related exhibits, is being furnished to the
Securities and Exchange Commission and shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liability of that Section. This information shall not be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific reference in such a
filing.
Add
LBMH.OB to Portfolio
Set Alert
Email to a
Friend